Scrip’s Five Must-Know Things – 16 October 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: BMS buys Mirati; slow Q3 for biopharma M&A; Roche on its neuroscience strategy; Alexion talks about AstraZeneca integration; and Gilead on trial diversity. https://scrip.citeline.com/SC149190/Quick-Listen-Scrips-Five-MustKnow-Things